P826: FACTOR D INHIBITION WITH ORAL BCX9930 LEADS TO SUSTAINED CONTROL OF HEMOLYSIS AND SYMPTOMS OVER 48 WEEKS IN SUBJECTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA INADEQUATELY CONTROLLED ON C5 INHIBITORS

Saved in:
Bibliographic Details
Published inHemaSphere Vol. 6; no. Suppl; pp. 720 - 721
Main Authors Kulasekararaj, A., Füreder, W., McDonald, A., Malherbe, J. L. R., Gandhi, S., Collins, D., Cornpropst, M., Dobo, S., Farmer, M. K., Kargl, D., Sheridan, W., Griffin, M., Risitano, A.
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Lippincott Williams & Wilkins 23.06.2022
Wiley
Online AccessGet full text

Cover

More Information
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000846188.51290.75